AI-Powered Post-Market Surveillance & Complaint Intelligence for MedTech
Medical device companies generate large volumes of post-market information from product complaints, adverse events, field service reports, distributor feedback, hospital communications, warranty claims, returned products and regulatory databases.
Collecting it is not the hard part. The hard part is deciding whether thousands of seemingly isolated events are beginning to reveal a product-performance or patient-safety signal.
AI-assisted complaint intelligence gives quality and regulatory teams a way to answer that question continuously. It is the device-side counterpart to pharmacovigilance signal detection in pharma, and it feeds the evidence that regulatory submissions, periodic safety update reports and PMCF plans require.
The Problem: Device Risk Signals Are Often Hidden Across Disconnected Systems
Complaint management is case-based by design. A complaint is received, investigated, assessed for reportability, documented and closed. Handling every case correctly does not mean the organisation is seeing the broader product risk early.
A seemingly minor malfunction can appear across different geographies, device lots, customer accounts, service records and clinical settings without anyone connecting the events.
Complaint data is also spread across the quality management system, email, call centres, service platforms, regulatory systems and spreadsheets.
The question MedTech organisations need to answer is bigger than any single case: are multiple post-market signals indicating that something about a device, manufacturing process, labelling or real-world use is beginning to change?
The Technology Solution
A post-market surveillance and complaint intelligence platform creates a connected intelligence layer across the device lifecycle.
Natural language processing and machine learning classify incoming complaints, extract the relevant device and event details, identify similar cases, assign standardised codes, prioritise potentially serious events and keep analysing the data for emerging patterns.
The flow: Complaint received → Device and event information extracted → Similar complaints identified → Reportability workflow initiated → Trend detected across lots or regions → Potential safety signal surfaced → Quality team investigates → CAPA or risk-management workflow triggered.
The platform also connects complaint intelligence with risk files, CAPA, manufacturing deviations, field service data and clinical evidence, so a signal is seen in the context of everything else known about the device.
Human quality and regulatory experts remain responsible for reportability and safety decisions. AI speeds up the analysis around them and documents every step.
Key Capabilities
- Automated complaint intake and classification across channels
- AI-assisted complaint triage
- Duplicate and similar-event detection
- Device, lot and failure-mode extraction
- Coding assistance (IMDRF adverse event terminology)
- Potential reportability prioritisation
- Complaint trending and cluster detection
- Emerging safety-signal identification
- Risk-file and CAPA linkage
- Field service and quality-data integration
- PMS and PSUR reporting support
- Human review, traceability and audit trails
Business Impact
Quality organisations move from case processing to proactive product surveillance.
Teams identify patterns earlier, cut repetitive manual work, make complaint categorisation more consistent and put expert time into the investigations that need engineering or clinical judgment.
At enterprise scale that means faster complaint processing, earlier detection of product risk, better regulatory readiness, stronger CAPA decisions, lower quality cost and better patient safety.
Post-market surveillance becomes a continuously learning product-intelligence system rather than a regulatory reporting exercise.
Build MedTech Post-Market Intelligence Platforms With Nirmitee
Nirmitee designs and engineers custom post-market surveillance, complaint management and device intelligence platforms for medical device organisations, integrated with existing QMS, regulatory, service, manufacturing, clinical and enterprise data environments. This work sits inside our PMS, PMCF and RWE platform practice, so complaint signals, PMCF follow-up and real-world device evidence are designed as one system rather than three.
Do not just close complaints. Detect what your complaints are trying to tell you. Talk to our team about your complaint volume and systems.
Frequently Asked Questions
- How does AI help with reportability decisions under EU MDR and FDA MDR rules?
The platform flags events that may meet reporting criteria, such as death, serious injury or a malfunction likely to cause either, and shows the extracted facts that triggered the flag against the relevant decision tree. The reportability decision, and the clock that starts with it, stays with the quality and regulatory team. The value is that potentially reportable events are prioritised on day one rather than found in a backlog.
- Does it integrate with our QMS?
Yes. Complaints stay in the quality management system as the system of record. The intelligence layer reads complaint, CAPA and risk-file data through the QMS's API or controlled exports, and writes classifications, similar-case links and signal alerts back, so investigators work from the system they already use.
- How does it support our PMS plan, PSURs and PMCF?
Trend analysis, complaint rates by product and lot and emerging-signal summaries are produced continuously, which is the data a periodic safety update report needs. Where a signal raises a clinical question, it can trigger a PMCF activity, and the same data model supports the post-market clinical follow-up and real-world evidence capture that a PMS plan requires.
- How do we validate an AI tool under ISO 13485 and 21 CFR Part 820?
As software used in the quality system: a defined intended use, risk-based validation with documented test cases, human review of every output that feeds a regulated decision, change control for model updates and periodic performance review. The platform is positioned as decision support, which keeps validation proportionate.
- What about complaints arriving by email, phone, distributors and service reports?
Intake across channels is where NLP earns its place. Emails, call transcripts, distributor forms and field service reports are read, the device, lot, event and outcome are extracted, duplicates across channels are linked, and the case is coded to standardised terminology before it reaches an investigator. That is usually the first stage teams put live.